A competitive enzyme immunoassay (cEIA) to determine the level of serum prealbumin is described. Antiserum to human serum prealbumin conjugated with peroxidase is incubated with solid-phase–bound human serum protein in the presence of sample or standard. The results obtained by the cEIA method (Y) correlate well with those obtained by the radial immunodiffusion method (X); Y = 1.03X + 5.92, r=0.93 for N=40. The coefficent of variations (CVs) of within-run assays (N=20) from three controls (99, 198, and 394 mg/L) are 7.2%, 5.2%, and 3.5%, respectively, and the CVs of between-run assays from the same three controls for 10 days are 8.3%, 5.7%, and 4.3%, respectively. Interference studies by the multiple regression model indicate that 0.2 g/dL (2 g/L) of added hemoglobin, 12 mg/dL (208 μ mol/L) of added bilirubin, and 545 mg/dL (6.2 mmol/L) of added triglycerides do not interfere significantly ( P <.01) with the assay. The assay is rapid (1 hour) and requires only commercially available reagents. Reference ranges of serum prealbumin for infants (aged 0 to 1 year), toddlers (aged 1 to 3 years), and preschool children (aged 3 to 6 years) are 47 to 187 mg/L, 95 to 307 mg/L, and 64 to 280 mg/L, respectively. There is not a significant difference in the serum prealbumin levels between the sexes of the subjects in the age groups studied. However, the reference range for infants is significantly lower ( P <.05) than those for the other two groups.
Read full abstract